Terms: = Prostate cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1
130 results:
1. AZGP1 deficiency promotes angiogenesis in prostate cancer.
Wen RM; Qiu Z; Marti GEW; Peterson EE; Marques FJG; Bermudez A; Wei Y; Nolley R; Lam N; Polasko AL; Chiu CL; Zhang D; Cho S; Karageorgos GM; McDonough E; Chadwick C; Ginty F; Jung KJ; Machiraju R; Mallick P; Crowley L; Pollack JR; Zhao H; Pitteri SJ; Brooks JD
J Transl Med; 2024 Apr; 22(1):383. PubMed ID: 38659028
[TBL] [Abstract] [Full Text] [Related]
2. The Effect of HMGB1 and HMGB2 on Transcriptional Regulation Differs in Neuroendocrine and Adenocarcinoma Models of prostate cancer.
Salamini-Montemurri M; Vizoso-Vázquez Á; Barreiro-Alonso A; Lorenzo-Catoira L; Rodríguez-Belmonte E; Cerdán ME; Lamas-Maceiras M
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542079
[TBL] [Abstract] [Full Text] [Related]
3. Pharmacological NF-κB inhibition decreases cisplatin chemoresistance in muscle-invasive bladder cancer and reduces cisplatin-induced toxicities.
Gil da Costa RM; Levesque C; Bianchi-Frias D; Chatterjee P; Lam HM; Santos C; Coleman IM; Ferreirinha P; Vilanova M; Pinto da Cunha N; Carvalho H; Moreira-Pais A; Faustino-Rocha A; Neto T; Batista da Costa J; Wright JL; Ferreira R; Oliveira PA; Mendes J; Bastos MMSM; Colaço B; Lopes C; Black PC; Sweeney CJ; Nelson PS
Mol Oncol; 2023 Dec; 17(12):2709-2727. PubMed ID: 37533407
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy of plasma atherogenic index in predicting malignancy in the presence of prostate Imaging-Reporting and Data System 3 (PI-RADS 3) prostate lesions.
Senel S; Ceviz K; Kasap Y; Tastemur S; Olcucuoglu E; Uzun E; Polat ME; Koudonas A; Sarialtin F
Int Urol Nephrol; 2023 Feb; 55(2):255-261. PubMed ID: 36357644
[TBL] [Abstract] [Full Text] [Related]
5. Identification of target and pathway of aspirin combined with Lipitor treatment in prostate cancer through integrated bioinformatics analysis.
Wang X; Wu Y; Liu J; Xu X; Sheng Z; Liu W; Chen M; Ma Y; Zhao D; Li D; Zheng X
Toxicol Appl Pharmacol; 2022 Oct; 452():116169. PubMed ID: 35926565
[TBL] [Abstract] [Full Text] [Related]
6. Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Lin HY; Ko CJ; Lo TY; Wu SR; Lan SW; Huang CA; Lin YC; Lin HH; Tu HF; Lee CF; Hsiao PW; Huang HP; Chen MJ; Chang KH; Lee MS
Oncogene; 2022 May; 41(20):2833-2845. PubMed ID: 35418692
[TBL] [Abstract] [Full Text] [Related]
7. Design of Metaheuristic Optimization-Based Vascular Segmentation Techniques for Photoacoustic Images.
Vaiyapuri T; Dutta AK; Sikkandar MY; Gupta D; Alouffi B; Alharbi A; Rauf HT; Kadry S
Contrast Media Mol Imaging; 2022; 2022():4736113. PubMed ID: 35173560
[TBL] [Abstract] [Full Text] [Related]
8. Inflammatory markers in women with reported benign gynecologic pathology: an analysis of the prostate, Lung, Colorectal and Ovarian cancer Screening Trial.
King LA; Wentzensen N; Purdue MP; Katki HA; Pinto LA; Trabert B
Ann Epidemiol; 2022 Apr; 68():1-8. PubMed ID: 34906633
[TBL] [Abstract] [Full Text] [Related]
9. Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line.
Weiner F; Schille JT; Koczan D; Wu XF; Beller M; Junghanss C; Hewicker-Trautwein M; Murua Escobar H; Nolte I
BMC Cancer; 2021 Oct; 21(1):1088. PubMed ID: 34625047
[TBL] [Abstract] [Full Text] [Related]
10. CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for pai-1.
Durlanik S; Fundel-Clemens K; Viollet C; Huber HJ; Lenter M; Kitt K; Pflanz S
Sci Rep; 2021 Jul; 11(1):14849. PubMed ID: 34290311
[TBL] [Abstract] [Full Text] [Related]
11. A Highly Specific Multiple Enhancement Theranostic Nanoprobe for PET/MRI/pai Image-Guided Radioisotope Combined Photothermal Therapy in prostate cancer.
Xia L; Meng X; Wen L; Zhou N; Liu T; Xu X; Wang F; Cheng Z; Yang Z; Zhu H
Small; 2021 May; 17(21):e2100378. PubMed ID: 33870644
[TBL] [Abstract] [Full Text] [Related]
12. [IgG4-related disease: about 3 cases].
Abid H; Alaoui MEHHBE; Lamrani MYA; Figuigui M; Ahmed BC; Lahmidani N; Yousfi ME; Benajah DA; Maaroufi M; Abkari ME; Ibrahimi SA; Aqodad N
Pan Afr Med J; 2020; 36():364. PubMed ID: 33235641
[TBL] [Abstract] [Full Text] [Related]
13. prostate cancer survivors with symptoms of radiation cystitis have elevated fibrotic and vascular proteins in urine.
Zwaans BMM; Nicolai HE; Chancellor MB; Lamb LE
PLoS One; 2020; 15(10):e0241388. PubMed ID: 33119677
[TBL] [Abstract] [Full Text] [Related]
14. The malignancy index is a robust predictor of prostate cancer.
Serafin AM; Chinhengo A; Akudugu JM
Discov Med; 2020; 29(158):181-189. PubMed ID: 33007193
[TBL] [Abstract] [Full Text] [Related]
15. Chelerythrine suppresses proliferation and metastasis of human prostate cancer cells via modulating MMP/TIMP/NF-κB system.
Yang B; Zhang D; Qian J; Cheng Y
Mol Cell Biochem; 2020 Nov; 474(1-2):199-208. PubMed ID: 32737771
[TBL] [Abstract] [Full Text] [Related]
16. Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy.
Deuker M; Rührup J; Karakiewicz PI; Welte M; Kluth LA; Banek S; Roos FC; Mandel P; Chun FK; Becker A
World J Urol; 2021 Apr; 39(4):1219-1226. PubMed ID: 32488362
[TBL] [Abstract] [Full Text] [Related]
17. [Long-Term Disease-Free Survival after Chemoradiotherapy for Postoperative Local Recurrence of Rectal cancer-A Case Report].
Kishimoto Y; Muroya D; Shirouzu Y; Kuratsu S; Kadoya K; Ishikawa H; Okabe M; Akagi Y
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2324-2326. PubMed ID: 32156919
[TBL] [Abstract] [Full Text] [Related]
18. Silencing of ELK3 Induces S-M Phase Arrest and Apoptosis and Upregulates serpine1 Expression Reducing Migration in prostate cancer Cells.
Mao Y; Li W; Hua B; Gu X; Pan W; Chen Q; Xu B; Wang Z; Lu C
Biomed Res Int; 2020; 2020():2406159. PubMed ID: 32104682
[TBL] [Abstract] [Full Text] [Related]
19. Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer.
Kimura S; D'Andrea D; Iwata T; Foerster B; Janisch F; Parizi MK; Moschini M; Briganti A; Babjuk M; Chlosta P; Karakiewicz PI; Enikeev D; Rapoport LM; Seebacher V; Egawa S; Abufaraj M; Shariat SF
World J Urol; 2020 Oct; 38(10):2501-2511. PubMed ID: 31797075
[TBL] [Abstract] [Full Text] [Related]
20. Examining the technical feasibility of prostate cancer molecular imaging by transrectal photoacoustic tomography with transurethral illumination.
Zhang H; Huang S; Chen Y; Xie W; Zhang M; Pan J; Sato N; Wang X; Wu D; Cheng Q
Exp Biol Med (Maywood); 2020 Feb; 245(4):313-320. PubMed ID: 31635491
[TBL] [Abstract] [Full Text] [Related]
[Next]
